)
Edge1 May 2026
Making the Marlboro Man
The story of Marlboro's transformation from a women's cigarette to a global icon: one of the most effective brand repositionings in history.
Tempest Therapeutics
Tempest Therapeutics (TPST) investor relations material
Tempest Therapeutics Registration filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Registration filing summary2 Apr, 2026
Company overview and business model
Clinical-stage biotechnology company with a diversified portfolio of cell therapy and small molecule product candidates targeting cancer and immunology indications.
Recently expanded pipeline through acquisition of dual-targeting CAR-T cell product candidates, including TPST-2003 for relapsed/refractory multiple myeloma.
Portfolio includes amezalpat (Phase 3-ready for hepatocellular carcinoma) and TPST-1495 (Phase 2 study in familial adenomatous polyposis, funded by the National Cancer Institute).
Incorporated in Delaware in 2011, headquartered in Brisbane, California.
Financial performance and metrics
Identified as a smaller reporting company with market value of public float under $700 million and annual revenue under $100 million.
Audited financials for the year ended December 31, 2025, include a going concern explanatory paragraph.
Use of proceeds and capital allocation
Will not receive proceeds from selling stockholders’ sales; will receive proceeds only from cash exercise of warrants.
Proceeds from warrant exercises will be used for general corporate purposes.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Tempest Therapeutics
- 8.27M shares registered for resale after a CAR-T asset acquisition; no proceeds to the company.TPST
Registration filing30 Mar 2026 - Transformative year with CAR-T asset acquisition, strong clinical data, and reduced net loss.TPSTQ4 202530 Mar 2026
- Amezalpat combo improved survival and response rates with strong safety in first-line liver cancer.TPSTStudy Update3 Feb 2026
- TPST-1120's phase II success in liver cancer propels a global phase III launch, with key data ahead.TPSTJefferies Global Healthcare Conference1 Feb 2026
- Amezalpat showed strong phase 2 survival benefits in liver cancer, with phase 3 FDA-backed plans.TPSTH.C. Wainwright 26th Annual Global Investment Conference 202421 Jan 2026
- Amezalpat demonstrated strong efficacy and safety in liver cancer, with a pivotal global trial planned.TPSTPiper Sandler 36th Annual Healthcare Conference12 Jan 2026
- Shareholders to vote on a major asset acquisition, rights plan extension, and equity plan increase.TPSTProxy Filing31 Dec 2025
- Shelf registration allows ongoing securities offerings with Jefferies LLC as sales agent.TPSTRegistration Filing16 Dec 2025
- Registering up to $300M in securities to fund late-stage oncology pipeline and corporate growth.TPSTRegistration Filing16 Dec 2025
Next Tempest Therapeutics earnings date
Q1 202615 May, 2026
Tempest Therapeutics
Next Tempest Therapeutics earnings date
Q1 202615 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage